Group One Trading’s Ascendis Pharma A/S ASND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-142
Closed -$26.5K 8373
2025
Q2
$24.5K Sell
142
-3,636
-96% -$592K ﹤0.01% 6124
2025
Q1
$589K Sell
3,778
-323
-8% -$46.1K ﹤0.01% 2926
2024
Q4
$565K Buy
+4,101
New +$539K ﹤0.01% 3071
2024
Q1
Sell
-5,808
Closed -$829K 7018
2023
Q4
$732K Buy
5,808
+2,964
+104% +$296K ﹤0.01% 2749
2023
Q3
$266K Buy
+2,844
New +$266K ﹤0.01% 3555
2023
Q1
Sell
-1,235
Closed -$141K 7176
2022
Q4
$151K Sell
1,235
-16,130
-93% -$1.87M ﹤0.01% 4091
2022
Q3
$1.79M Buy
17,365
+11,321
+187% +$1.07M ﹤0.01% 2011
2022
Q2
$562K Buy
+6,044
New +$570K ﹤0.01% 3304
2021
Q3
Sell
-11
Closed -$1.5K 8146
2021
Q2
$1K Sell
11
-220
-95% -$29.3K ﹤0.01% 7996
2021
Q1
$30K Sell
231
-710
-75% -$108K ﹤0.01% 6547
2020
Q4
$157K Buy
+941
New +$156K ﹤0.01% 4238
2020
Q2
Sell
-569
Closed -$78.1K 5769
2020
Q1
$64K Sell
569
-1,219
-68% -$158K ﹤0.01% 3567
2019
Q4
$249K Buy
1,788
+565
+46% +$62.8K ﹤0.01% 3010
2019
Q3
$118K Sell
1,223
-4,392
-78% -$490K ﹤0.01% 3444
2019
Q2
$647K Buy
+5,615
New +$672K 0.01% 1911
2019
Q1
Sell
-1,345
Closed -$118K 4768
2018
Q4
$84K Buy
+1,345
New +$84.5K ﹤0.01% 3280
2018
Q3
Sell
-98
Closed -$6.75K 5163
2018
Q2
$7K Buy
+98
New +$6.45K ﹤0.01% 4705

Other funds holding ASND

Group One Trading's ASND Position: Q3 2025 in Review

Group One Trading sold out of Ascendis Pharma A/S (ASND) in Q3 2025, closing a stake of 142 shares — an estimated $26.5K sold.

Group One Trading first reported a position in ASND in Q2 2018 and held it in 17 quarters. The position peaked at $1.79M in Q3 2022. 279 funds tracked by Wall St. Rank hold ASND as of Q3 2025.

  • Group One Trading reported no remaining Ascendis Pharma A/S position as of Q3 2025 after selling out during the quarter.
  • Group One Trading sold 142 Ascendis Pharma A/S shares in Q3 2025, an estimated $26.5K.
  • Group One Trading first reported a position in Ascendis Pharma A/S in Q2 2018 and held it in 17 quarters.
  • Group One Trading's Ascendis Pharma A/S position peaked at $1.79M in Q3 2022.
  • 279 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q3 2025.

Based on Group One Trading's 13F filing for Q3 2025, filed 12 Nov 2025.